SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 10th, 2018 • Immune Pharmaceuticals Inc • Pharmaceutical preparations • Virgin Islands
Contract Type FiledOctober 10th, 2018 Company Industry JurisdictionThis Securities Purchase Agreement (“Agreement”) is made and entered into on October 9, 2018 (“Effective Date”), by and between Immune Pharmaceuticals, Inc., a Delaware corporation (“Company”), and the investor whose name appears on the signature page hereto (“Investor”).